IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1167/iovs.07-1421 on March 24, 2008
 (Investigative Ophthalmology and Visual Science. 2008;49:3289-3298.)
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.07-1421
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
iovs.07-1421v1
49/8/3289    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Halfter, W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halfter, W.

Change in Embryonic Eye Size and Retinal Cell Proliferation following Intravitreal Injection of Glycosaminoglycans

Willi Halfter

From the Department of Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania.

PURPOSE. The vitreous body (VB) is a transparent, extracellular matrix structure that fills the vitreous cavity of the eye. Major constituents of the VB are hyaluronic acid (HA) and glycosaminoglycans (GAGs), both of which are highly charged, linear carbohydrate polymers. The present experiments investigate a possible role of HA and GAGs in regulating eye size during development and investigate whether changes in eye size are synchronized with cell proliferation in the retina.

METHODS. Chondroitin sulfate (CS), heparan sulfate (HS), heparin (Hep), dextran sulfate (DexS), and HA were injected into the vitreous cavity of embryonic day 5 chick embryos. Eye size was assessed 1 to 5 days after the injections. Cell counts and BrdU labeling established whether changes in eye size were paralleled by an increase or a decrease in retinal cell proliferation.

RESULTS. Injection of CS and HS led to an increase in eye size that was accompanied by a similar increase in retinal cell numbers. Hep and DexS injections led to a decrease in eye size that had no impact on cell proliferation in the retina. HA application had no effect on eye size.

CONCLUSIONS. The changes in eye size after intravitreal application of GAGs demonstrate that the composition of the VB can play an important role in the regulation of eye size during embryogenesis. The fact that retinal cell proliferation is elevated after an increase in eye size indicates a regulatory role of eye size for retinal cell numbers.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Association for Research in Vision and Ophthalmology